Delivery Order SPE2DB24D2205-SPE2DB25FEFHN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,306.80 to AmerisourceBergen Drug Corp for the supply of BOTOX 100 Unit Vials. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 6, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate office location in Conshohocken, PA. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $6,460.20 to AmerisourceBergen Drug Corp for the supply of BOTOX 100 Unit Vials, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger relationship with DLA. The pharmaceutical products will be delivered to the company's location in Conshohocken, Pennsylvania, supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Botox 100 Unit Vials with a ceiling value of $10,336.32. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation, reflecting open competition among eligible vendors. This delivery...
- The Defense Logistics Agency awarded a $4,306.80 delivery order to AmerisourceBergen Drug Corp for the supply of Botox 100 unit vials, with an ultimate completion date of August 25, 2025. This is a firm fixed-price, non-set-aside contract with performance taking place in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,445.44 to AmerisourceBergen Drug Corp for the supply of Botox 100 unit vials. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of June 24, 2025. The contract is being performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $8,613.60 to AmerisourceBergen Drug Corp for the supply of BOTOX 100 Unit Vials. This competitively awarded, firm fixed-price contract has a completion date of August 22, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's existing federal contract vehicle with DLA Troop Support Medical. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $6,838.32 on June 18, 2025, for the supply of Botox 200 Unit Vials, with completion expected by July 11, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The award carries no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $20,514.96 to AmerisourceBergen Drug Corp for BOTOX 200 unit vials on July 15, 2025, with an ultimate completion date of August 5, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location and...
- The Defense Logistics Agency awarded a delivery order valued at $12,045.00 to AmerisourceBergen Drug Corp for the supply of BOTOX 200 Unit Vials. The contract is a firm fixed price delivery order with a completion date of August 27, 2025, and was awarded on August 6, 2025 without a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $7,227 to AmerisourceBergen Drug Corp for BOTOX 200 unit vials, with an ultimate completion date of August 27, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFHNDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Botox 100 Unit Vials under a Firm Fixed Price contract. The delivery order, valued at $6,460.20, carries an ultimate completion date of August 14, 2025, and was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The contract supports various federal customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 7/24/25 |